Olectan (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxomil, the active ingredient in Olectan, is a combination antihypertensive presented as a tablet for oral use. It treats hypertension in adults, often when monotherapy does not provide adequate blood pressure control.

GNH USA supplies Olectan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olectan is used in the management of high blood pressure, a key component of cardiovascular disease prevention. - Hypertension: lowers systolic and diastolic blood pressure to reduce risk of stroke and heart attack. - Hypertension in patients who require dual therapy: provides combined angiotensin‑II receptor blockade and calcium‑channel blockade. - Hypertension with concomitant edema risk: amlodipine’s vasodilatory effect mitigates fluid retention associated with ARBs.

Adverse reactions may occur with any antihypertensive combination therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Dizziness or light‑headedness, especially after the first dose. - Flushing: transient warmth and redness. - Fatigue: general tiredness. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Angio‑edema: rapid swelling of lips, tongue or airway. - Severe hypotension: symptomatic low blood pressure. - Hepatic dysfunction: elevated liver enzymes. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated potassium levels. - Myocardial infarction: rare but reported in susceptible patients.

Before initiating Olectan, clinicians should assess patient history and comorbid conditions. - Renal impairment: adjust dose or monitor renal function regularly. - Hepatic disease: use with caution; monitor liver enzymes. - Electrolyte disturbances: check potassium and sodium levels. - Pregnancy: contraindicated in the second and third trimesters; avoid use. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Olectan may interact with several drug classes; careful review of the patient’s medication list is essential.

Major Interactions (Avoid): - Potassium‑rich supplements or potassium‑sparing diuretics: risk of hyper‑kalemia. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): increase amlodipine exposure. - Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs): excess hypotension.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect. - Diuretics: additive blood‑pressure lowering, monitor electrolytes. - Antidiabetic agents: may enhance glucose‑lowering effect, requiring dose adjustment.